LEN vs PROF
LEN (LEN) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
LEN does not have a complete income-statement cache yet.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
LEN currently screens at market cap $0. PROF currently screens at market cap $238.7M.
Not investment advice. Open the LEN and PROF stock pages for the full models.
Not investment advice.